UroLift: a new minimally-invasive treatment for benign prostatic hyperplasia

Patrick Jones; Bhavan P Rai; Omar Aboumarzouk; Bhaskar K Somani

doi:10.1177/1756287216671497

UroLift: a new minimally-invasive treatment for benign prostatic hyperplasia

Ther Adv Urol. 2016 Dec;8(6):372-376. doi: 10.1177/1756287216671497. Epub 2016 Oct 10.

Authors

Patrick Jones¹, Bhavan P Rai², Omar Aboumarzouk³, Bhaskar K Somani⁴

Affiliations

¹ Department of Urology, Blackpool Victoria Hospital, Blackpool, UK.
² James Cook University Hospital, South Tees Hospital NHS Foundation Trust, UK.
³ Department of Urology, Bristol Urological Institute, Bristol, UK.
⁴ Department of Urology, University Hospital Southampton NHS Trust, Tremona Road, Southampton SO16 6YD, UK.

Abstract

'UroLift' has emerged as a new minimally-invasive nonablative surgical technique for benign prostatic hyperplasia (BPH). We discuss the procedure, cost, evidence, advantages and disadvantages of this procedure. It is a novel technology suitable for a selected group of patients that allows for a bespoke treatment for men with BPH.

Keywords: BPH; PUL; UroLift; prostate.

Publication types

Review